US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist

2.120
-0.080-3.64%

Close Oct 31 16:00 ET

2.110
-0.010-0.47%

Post 16:06 ET

74.00MMarket Cap-677P/E (TTM)

RAPT Therapeutics Stock Forum

Stock_Drift

Apr 12 02:05

Friday Stuff. 🍿⚡️🍿⚡️🍿

$RAPT Therapeutics (RAPT.US)$

Meltyy

Apr 2 22:13

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

Angeler

Feb 22 07:17

$RAPT Therapeutics (RAPT.US)$
Yesterday My support Halt up ♥️🌹✈️
My people rich? ♥️🌹✈️

Jonathan Mini

Feb 21 09:26

$RAPT Therapeutics (RAPT.US)$ 28% in 1hr 43min. I'll take it. 7.34 to 9.40 🤑

MangoXXXX

Feb 21 09:08

$RAPT Therapeutics (RAPT.US)$ 😮👀

MangoXXXX

Feb 21 08:33

$RAPT Therapeutics (RAPT.US)$ ⬆️ and ⬆️

Angeler

Feb 21 06:19

$RAPT Therapeutics (RAPT.US)$
buy or no buy? 🙊
GP morgan? ,🙈
Offering NEWS? 🙈
wat ta fut 😂😝

Moomoo AI

Feb 20 07:43

The experimental inflammation drug was seen as having 'pipeline-in-a-product' potential, meaning it could be effective in treating a range of conditions. However, the recent clinical hold by the FDA could significantly impact the development and potential of zelnecirnon.

RAPT Therapeutics' Stock Plunges as FDA Halts Two Clinical Trials

Moomoo AI

Feb 13 07:06

Nipun Davar's appointment, with his vast experience in small molecule product development and commercial manufacturing, is a major boost for RAPT's leadership team as they progress their drug candidates zelnecirnon and tivumecirnon in late-stage clinical trials for inflammatory diseases and oncology indications.